|
rs1060501199
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
|
rs28897701
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
|
rs4778889
|
|
|
0.020 |
GeneticVariation |
BEFREE |
IL-16 rs4778889 polymorphism contribution to the development of renal cell cancer in a Chinese population.
|
27323152 |
2016 |
|
rs4778889
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Interleukin-16 rs4778889 polymorphism contributes to the development of renal cell cancer in a Chinese population.
|
26823871 |
2015 |
|
rs6721961
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Nrf2 gene mutation and single nucleotide polymorphism rs6721961 of the Nrf2 promoter region in renal cell cancer.
|
31752777 |
2019 |
|
rs11614913
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Although for rs11614913 and rs3746444 polymorphisms, overall analyses suggested negative results, for rs11614913 polymorphism, when subgroup analysis was conducted by cancer type, a significantly decreased risk of renal cell cancer was identified in recessive model.
|
29491365 |
2018 |
|
rs3746444
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Although for rs11614913 and rs3746444 polymorphisms, overall analyses suggested negative results, for rs11614913 polymorphism, when subgroup analysis was conducted by cancer type, a significantly decreased risk of renal cell cancer was identified in recessive model.
|
29491365 |
2018 |
|
rs2228230
|
|
|
0.010 |
GeneticVariation |
BEFREE |
In patients with localized renal cell cancer, 5 of these polymorphisms in 3 genes involved in angiogenesis predicted for worse disease free survival (VEGFR2: rs10013228; PDGFRA: rs2228230) or shorter overall survival (VEGFR2: rs10013228; VEGFR3: rs6877011, rs307826) (<i>p</i> < 0.05).
|
29290970 |
2017 |
|
rs4680
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We suggest that bladder cancer but not prostate cancer and kidney cancer could be significantly associated with the Val158Met polymorphism.
|
27055785 |
2016 |
|
rs1049380
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Kidney cancer developed at an older age in patients carrying the dominant risk allele A for rs7105934 (mean age at diagnosis 73.1 vs 68.9 years, p = 0.002) and at a younger age in those carrying the dominant allele C for rs1049380 (mean 68.1 vs 70.8 years, p = 0.005).
|
23911636 |
2014 |
|
rs1056836
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Previous studies have reported the existence of CYP1B1 L432V missense polymorphism in prostate, bladder and renal cancers.
|
24913727 |
2014 |
|
rs4938723
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Overall, the current study suggests that the miR-34b/c rs4938723 polymorphism may be associated with the risk of cancers, including nasopharyngeal cancer, osteosarcoma, and renal cell cancer, and to some extent this polymorphism is closely related to cancer susceptibility in Asians.
|
25326793 |
2014 |
|
rs7105934
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Kidney cancer developed at an older age in patients carrying the dominant risk allele A for rs7105934 (mean age at diagnosis 73.1 vs 68.9 years, p = 0.002) and at a younger age in those carrying the dominant allele C for rs1049380 (mean 68.1 vs 70.8 years, p = 0.005).
|
23911636 |
2014 |
|
rs2243250
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Taken together, our results indicated that IL-4 rs2243250 polymorphism was associated with decreased oral cancer risk in both the homozygote contrasts and the dominant genetic model, as well as increased renal cell cancer risk in both the homozygote contrasts and the recessive genetic model.
|
23572437 |
2013 |
|
rs833061
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We were unable to replicate the association of the -460T/C (rs833061) polymorphism with renal cancer risk.
|
23073296 |
2013 |
|
rs1045642
|
|
|
0.010 |
GeneticVariation |
BEFREE |
In summary, this meta-analysis suggests that the MDR1 C3435T polymorphism is associated with cancer susceptibility, increasing the risk of breast and renal cancer.
|
22358302 |
2012 |
|
rs1805010
|
|
|
0.010 |
GeneticVariation |
BEFREE |
I75V G allele carriers were associated with a decreased risk of renal cancer (dominant model = 0.71, 95%CI = 0.57-0.89, heterozygote comparison: OR = 0.69, 95%CI = 0.55-0.87).
|
23464436 |
2012 |
|
rs662
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Investigating paraoxonase-1 gene Q192R and L55M polymorphism in patients with renal cell cancer.
|
21308654 |
2011 |
|
rs854560
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Investigating paraoxonase-1 gene Q192R and L55M polymorphism in patients with renal cell cancer.
|
21308654 |
2011 |
|
rs5030805
|
|
|
0.010 |
GeneticVariation |
BEFREE |
To our knowledge, the Ser80Ile mutation has not been previously described in VHL type 2 patients with high risk of pheochromocytoma and renal cell cancer.
|
18416845 |
2008 |
|
rs1057520001
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We genotyped three single nucleotide polymorphisms of three genes (p53 Arg(72)Pro, p21 Ser(31)Arg, and MDM2 SNP309) in 200 patients with renal cancer and 200 age- and gender-matched healthy subjects.
|
17634539 |
2007 |
|
rs886039484
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We genotyped three single nucleotide polymorphisms of three genes (p53 Arg(72)Pro, p21 Ser(31)Arg, and MDM2 SNP309) in 200 patients with renal cancer and 200 age- and gender-matched healthy subjects.
|
17634539 |
2007 |
|
rs17879961
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The missense variant I157T was associated with an increased risk of breast cancer (OR 1.4; P=.02), colon cancer (OR 2.0; P=.001), kidney cancer (OR 2.1; P=.0006), prostate cancer (OR 1.7; P=.002), and thyroid cancer (OR 1.9; P=.04).
|
15492928 |
2004 |